Zoetis Inc. (ZTS) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $114.14 (-0.76%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 26, 2026 | Mark Massaro | BTIG | $160.00 | +40.2% |
| Jan 22, 2026 | David Westenberg | Piper Sandler | $135.00 | +18.3% |
| Aug 11, 2025 | David Westenberg | Piper Sandler | $215.00 | +88.4% |
| Jun 17, 2025 | Jonathan Block | Stifel Nicolaus | $160.00 | +40.2% |
| May 7, 2025 | Andrea Alfonso | UBS | $170.00 | +48.9% |
| Apr 14, 2025 | Jonathan Block | Stifel Nicolaus | $165.00 | +44.6% |
| Feb 4, 2025 | Erin Wright | Morgan Stanley | $243.00 | +112.9% |
| Aug 7, 2024 | Balaji Prasad | Barclays | $242.00 | +112.0% |
| Aug 5, 2024 | Jonathan Block | Stifel Nicolaus | $200.00 | +75.2% |
| Apr 16, 2024 | David Westenberg | Piper Sandler | $195.00 | +70.8% |
| Apr 2, 2024 | Jonathan Block | Stifel Nicolaus | $195.00 | +70.8% |
| Feb 21, 2022 | David Steinberg | Jefferies | $254.00 | +122.5% |
| Aug 25, 2021 | Jasper Hellweg | Argus Research | $225.00 | +97.1% |
| Aug 9, 2021 | Katie Tryhane | Credit Suisse | $230.00 | +101.5% |
Top Analysts Covering ZTS
ZTS vs Sector & Market
| Metric | ZTS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.56 | 2.24 | 2.41 |
| Analyst Count | 9 | 8 | 18 |
| Target Upside | +25.3% | +1150.2% | +14.9% |
| P/E Ratio | 18.96 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.83B | $9.90B | $10.00B | 15 |
| 2027-03-31 | $2.36B | $2.40B | $2.45B | 5 |
| 2027-06-30 | $2.64B | $2.68B | $2.73B | 5 |
| 2027-09-30 | $2.60B | $2.64B | $2.69B | 5 |
| 2027-12-31 | $2.58B | $2.62B | $2.68B | 5 |
| 2028-03-31 | $2.45B | $2.49B | $2.54B | 4 |
| 2028-06-30 | $2.76B | $2.80B | $2.86B | 4 |
| 2028-09-30 | $2.69B | $2.73B | $2.79B | 4 |
| 2028-12-31 | $2.66B | $2.70B | $2.75B | 4 |
| 2029-12-31 | $11.22B | $11.37B | $11.56B | 12 |
| 2030-12-31 | $11.70B | $11.86B | $12.05B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $7.00 | $7.03 | $7.06 | 12 |
| 2027-03-31 | $1.68 | $1.72 | $1.76 | 5 |
| 2027-06-30 | $2.00 | $2.04 | $2.09 | 5 |
| 2027-09-30 | $1.92 | $1.96 | $2.01 | 5 |
| 2027-12-31 | $1.74 | $1.78 | $1.83 | 5 |
| 2028-03-31 | $1.75 | $1.79 | $1.84 | 7 |
| 2028-06-30 | $2.13 | $2.17 | $2.23 | 6 |
| 2028-09-30 | $2.03 | $2.07 | $2.13 | 6 |
| 2028-12-31 | $1.76 | $1.80 | $1.85 | 7 |
| 2029-12-31 | $8.57 | $8.72 | $8.90 | 1 |
| 2030-12-31 | $9.11 | $9.27 | $9.47 | 1 |
Frequently Asked Questions
What is the analyst consensus for ZTS?
The consensus among 9 analysts covering Zoetis Inc. (ZTS) is Hold with an average price target of $143.86.
What is the highest price target for ZTS?
The highest price target for ZTS is $254.00, set by David Steinberg at Jefferies on 2022-02-21.
What is the lowest price target for ZTS?
The lowest price target for ZTS is $135.00, set by David Westenberg at Piper Sandler on 2026-01-22.
How many analysts cover ZTS?
9 analysts have issued ratings for Zoetis Inc. in the past 12 months.
Is ZTS a buy or sell right now?
Based on 9 analyst ratings, ZTS has a consensus rating of Hold (2.56/5) with a +25.3% upside to the consensus target of $143.86.
What are the earnings estimates for ZTS?
Analysts estimate ZTS will report EPS of $7.03 for the period ending 2026-12-31, with revenue estimated at $9.90B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.